Literature DB >> 24559975

Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma.

Ben Gurney1, Carrie Newlands2.   

Abstract

This overview is the first of 2 articles on the current evidence for management of the neck and parotid in cutaneous cancers of the head and neck. In this paper we discuss cutaneous squamous cell carcinoma (SCC) and review the latest evidence for management of the regional nodes.
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cutaneous squamous cell carcinoma; Lymphatic metastasis; Neck dissection; Radiotherapy

Mesh：

Year:  2014        PMID： 24559975     DOI： 10.1016/j.bjoms.2014.01.015

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  12 in total

Review 1.  Hide-and-seek: Neurotropic squamous cell carcinoma of the periorbital region - a series of five cases and review of the literature.

Authors:  Evi M Morandi; Tina Rauchenwald; Petra Puelzl; Bernhard W Zelger; Bettina G Zelger; Benjamin Henninger; Gerhard Pierer; Dolores Wolfram
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231

2.  Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.

Authors:  Jaakko S Knuutila; Pilvi Riihilä; Samu Kurki; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Acta Derm Venereol       Date:  2020-09-23       Impact factor: 3.875

3.  Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  C Newlands; R Currie; A Memon; S Whitaker; T Woolford
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

Review 4.  Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.

Authors:  Joanna M Janus; Ryan F L O'Shaughnessy; Catherine A Harwood; Tania Maffucci
Journal:  Cancers (Basel)       Date:  2017-07-11       Impact factor: 6.639

5.  Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.

Authors:  Jay H Kalin; Abdulkerim Eroglu; Hua Liu; W David Holtzclaw; Irene Leigh; Charlotte M Proby; Jed W Fahey; Philip A Cole; Albena T Dinkova-Kostova
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

Review 6.  Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives.

Authors:  Andrea Alberti; Paolo Bossi
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

Review 7.  Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.

Authors:  A Nasrallah; N Fayyad; F Kobaisi; B Badran; H Fayyad-Kazan; M Fayyad-Kazan; M Sève; W Rachidi
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

8.  Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).

Authors:  Jean-Jacques Grob; Rene Gonzalez; Nicole Basset-Seguin; Olga Vornicova; Jacob Schachter; Abhishek Joshi; Nicolas Meyer; Florent Grange; Josep M Piulats; Jessica R Bauman; Pingye Zhang; Burak Gumuscu; Ramona F Swaby; Brett G M Hughes
Journal:  J Clin Oncol       Date:  2020-07-16       Impact factor: 44.544

Review 9.  Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.

Authors:  Jean Christopher Chamcheu; Tithi Roy; Mohammad Burhan Uddin; Sergette Banang-Mbeumi; Roxane-Cherille N Chamcheu; Anthony L Walker; Yong-Yu Liu; Shile Huang
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

Review 10.  Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review.

Authors:  Tito Brambullo; Gian Paolo Azzena; Paolo Toninello; Giuseppe Masciopinto; Alberto De Lazzari; Bernardo Biffoli; Vincenzo Vindigni; Franco Bassetto
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.